Croatia HALMED · August 05, 2026

Obligation to submit a variation application following PSUSA procedure

HALMED publishes outcomes of PSUSA procedures for medicinal products authorised in Croatia and instructs marketing authorisation holders on required variation applications.

High obligation Sector Pharmaceuticals CroatiaEU-wide Pharmacovigilance

Agency for Medicinal Products and Medical Devices of Croatia (HALMED) has published information on the outcomes of the PSUSA procedures, which include medicinal products authorised in the Republic of Croatia. Stated information is available in theMedicinal products/ Variation applications - referrals, PSUSA procedures and PRAC signals/ Instructions for variation applications following the outcome of the PSUSA proceduresection on the HALMED's website. The table is updated with the PSUSA outcomes for the following active substances: In accordance with Art. 50 of the Medicinal Products Act (OG76/13,90/14,100/18and136/25) and Art. 16 of Regulation (EC) No 726/2004, marketing authorisation holders are required to ensure that the information on

Read the official source ↗

Published by Croatia HALMED. HealthSignal links to the original document; the summary above is extracted from the source text.